NEW DELHI: The US multinational Johnson & Johnson on Friday applied for Emergency Use Authorisation for its single-dose Covid-19 vaccine in India. Once approved, this would be the maiden single dose vaccine to be approved for use in the country. The company said it would bring the supply line to India through partnership with domestic firm Biological E Limited here.
India is yet to work out legal arrangements with Pfizer and other foreign-made vaccines.